Differential RNA expression of the PS2 gene in the human benign and malignant prostatic tissue

Journal of Urology

Volumn 162, Issue 3 I, 1999, Pages 927-930

  Colombel, Marc ^a   Dante, Robert ^b   Bouvier, Raymonde ^b   Ribieras, Stephanne ^b   Pangaud, Catherine ^b   Marechal, Jean Marie ^b   Lasne, Yves ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b NONE

Author keywords

Gene expression; Prostate cancer; PS2

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN PS2; RNA;

ARTICLE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032833560     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199909010-00092     Document Type: Article

References (28)

1. Abiin, R. J.: A retrospective and prospective overview of prostate-specific antigen. J. Cancer Res. Clin. Oncol., 123:583, 1997.
2. Dorkin, T. J., Robson, C. N. and Neal, D. E.: The molecular pathology of urological malignancies. J. Pathol., 183: 380, 1997.
3. Isaacs, J. T.: Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am. J. Pathol., 150: 1511, 1997.
4. Franks, L. M.: Prostatic cancer: future prospects for diagnosis and screening. Br. J. Urol., 79 (Suppl. 1): 107, 1997.
5. Jakowlew, S. B., Breathnach, R., Jeltsch, J. M., Masiakowski, P. and Chambon, P.: Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res., 12: 2861, 1984.
6. Jeltsch, J. M., Roberts, M., Schatz, C., Garnier, J. M., Brown, A. M. and Chambon, P.: Structure of the human oestrogen-responsive gene pS2. Nucleic Acids Res., 15: 1401, 1987.
7. Foekens, J. A., Rio, M. C., Seguin, P., van Putten, W. L., Fauque, J., Nap, M., Klijn, J. G. and Chambon, P.: Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res., 50: 3832, 1990.
8. Henry, J. A., Nicholson, S., Hennessy, C., Lennard, T. W., May, F. E. and Westley, B. R.: Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br. J. Cancer, 61: 32, 1990.
9. Henry, J. A., Piggott, N. H., Mallick, U. K., Nicholson, S., Farndon, J. R., Westley, B. R. and May, F. E.: pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br. J. Cancer, 63: 615, 1991.
10. Lefebvre, O., Chenard, M. P., Masson, R., Linares, J., Dierich, A., LeMeur, M., Wendling, C., Tomasetto, C., Chambon, P. and Rio, M. C.: Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein [see comments]. Science, 274: 259, 1996.
11. Luqmani, Y. A., Ryall, G., Shousha, S. and Coombes, R. C.: An immunohistochemical survey of pS2 expression in human epithelial cancers. Int. J. Cancer, 50: 302, 1992.
12. Luqmani, Y., Bennett, C., Paterson, I., Corbishley, C. M., Rio, M. C., Chambon, P. and Ryall, G.: Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int. J. Cancer, 44: 806, 1989.
13. Wysocki, S. J., Hahnel, E., Masters, A., Smith, V., McCartney, A. J. and Hahnel, R.: Detection of pS2 messenger RNA in gynecological cancers. Cancer Res., 50: 1800, 1990.
14. Bonkhoff, H., Stein, U., Welter, C. and Remberger, K.: Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum. Pathol., 26: 824, 1995.
15. Gleason, D. F. and Mellinger, G.: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58, 1974.
16. Chomczynski, P.and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
17. Fuqua, S. A., Falette, N. F. and McGuire, W. L.: Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay [see comments]. JNCI, 82: 858, 1990.
18. Henry, J. A., Bennet, M. K., Piggot, N. H., Levett, D. L., May, F. E. B. and Westley, B. R.: Expression of pN-2/pS2 protein in diverse human epithelial tumours. Br. J. Cancer, 64: 677, 1991.
19. Ioakim-Liossi, A., Karakitsos, P., Markopoulos, C., Aroni, K., Delivelioti, K., Gogas, J. and Kyrkou, K.: Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer. Acta Cytol., 41: 713, 1997.
20. Ioakim-Liossi, A., Karakitsos, P., Aroni, K., Markopoulos, C., Delivelioti, K., Gogas, J. and Kyrkou, K.: DNA ploidy and pS2 protein expression in breast cancer. Cytopathology, 8: 171, 1997.
21. May, F. E. and Westley, B. R.: Trefoil proteins: their role in normal and malignant cells. J. Pathol., 183: 4, 1997.
22. Khan, S. A., Gonchoroff, N. J. and Miller, L. E.: Expression of pS2, c-erbB-2, and cathepsin D during the menstrual cycle in human breast cancers. Ann. Surg. Oncol., 4: 462, 1997.
23. Weigel, N. L. and Zhang, Y.: Ligand-independent activation of steroid hormone receptors. J. Mol. Med., 76: 469, 1998.
24. Sauter, E. R., Babb, J., Daly, M., Engstrom, P. F., Ehya, H., Malick, J. and Diamandis, E.: Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol. Biomarkers Prev., 7: 315, 1998.
25. Nunez, A. M., Berry, M., Imler, J. L. and Chambon, P.: The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J., 8: 823, 1989.
26. Rio, M. C., Chenard, M. P., Wolf, C., Marcellin, L., Tomasetto, C., Lathe, R., Bellocq, J. P. and Chambon, P.: Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterol., 100: 375, 1991.
27. Dante, R., Ribieras, S., Baldassini, S., Martin, V., Benzerara, O., Bouteille, C., Bremond, A., Frappart, L., Rio, M. C. and Lasne, Y.: Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts. Lab. Invest., 71: 188, 1994.
28. Speiser, P., Mayerhofer, K., Kucera, E., Roch, G., Mittelbock, M., Gitsch, G. and Zeillinger, R.: pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters. Anticancer Res., 17: 679, 1997.